• Wed news: Gilead HIV pipeline. Walgreens may go private. How Trump 2.0 will affect medtech. Lilly to offer Zepbound via Ro Telehealth. Pharma’s regulatory optimism. See more on our front page

Layoffs 100%







It’s 2016 all over again…..
Boehringer Ingelheim announced layoffs in late November 2016, specifically on Thursday, December 1, 2016. The company confirmed plans to eliminate approximately 244 positions across the United States, with about 180 of those cuts occurring in Connecticut. This decision was part of a broader restructuring strategy, which included closing the small molecule discovery functions at their Ridgefield, Connecticut facility.

The layoffs were part of a series of reductions in 2016. Earlier that year, in June, Boehringer Ingelheim had announced the elimination of 724 jobs across the U.S., primarily affecting sales positions.

Therefore, while there were significant layoffs announced around that time, there is no specific information indicating that Boehringer Ingelheim conducted layoffs on the Tuesday after Thanksgiving in 2016.
 






Boehringer Ingelheim announced layoffs in late November 2016, specifically on Thursday, December 1, 2016. The company confirmed plans to eliminate approximately 244 positions across the United States, with about 180 of those cuts occurring in Connecticut. This decision was part of a broader restructuring strategy, which included closing the small molecule discovery functions at their Ridgefield, Connecticut facility.

The layoffs were part of a series of reductions in 2016. Earlier that year, in June, Boehringer Ingelheim had announced the elimination of 724 jobs across the U.S., primarily affecting sales positions.

Therefore, while there were significant layoffs announced around that time, there is no specific information indicating that Boehringer Ingelheim conducted layoffs on the Tuesday after Thanksgiving in 2016.
There is a delay in necessary decision making data. Won’t happen until 2025! Happy New Year!
 












BI is a joke. First you can cut marketing and the RMLs. Then keep a KAM or SAM but not both. Layoff half to 2/3 of MSLs. All the ONE’s until closer to an oncology approval. One zone and 40% of OSC’s. Way too much staff for one potential oncology drug with a tiny indication. And the DLL3 IF approved won’t be until 2026-2027. It’s the JV team. BI promoted internal candidates in sales leadership, marketing, RML and SAMs with zero oncology experience. They know no KOLs, no institutions and only care about metrics. It’s a shit show of incompetence. Stay very far away.
 






CRM is in trouble. How are you going to sell a drug with a generic equivalent? Jardiance and Farxiga are no different and we all know it. There’s no way BI can keep all these reps. No one should be surprised by this. There is nothing in the pipeline for years. They can say no layoffs but it makes no logical sense to keep this many reps to sell a branded drug that has a generic equivalent as of 2025.
 












CRM is in trouble. How are you going to sell a drug with a generic equivalent? Jardiance and Farxiga are no different and we all know it. There’s no way BI can keep all these reps. No one should be surprised by this. There is nothing in the pipeline for years. They can say no layoffs but it makes no logical sense to keep this many reps to sell a branded drug that has a generic equivalent as of 2025.
Agree! Good luck to you all
 








































































Actually would not be bad for me for the 60 day warn to begin early Dec .. only 1year away from retirement.. so as I understand it after warn expect 4 weeks automatic plus 2weeks for every good year..lets face it CRM is bloated but I am Met ..logically however BI should CAN Cardio because they do so very little and get the most pay .. and Met would visit the very few Cardiologist and Neph that still allow Reps in the door plus Endo and Primary.. for one rep per territory they would be enough work to actually keep me busy.. But if I know BI they will keep Cardio and CAN Primary like me.. I can only hope that BI continues to make illogical decisions .. Happy Holidays to all